Literature DB >> 26653746

Determination of 20 trace elements and arsenic species for a realgar-containing traditional Chinese medicine Niuhuang Jiedu tablets by direct inductively coupled plasma-mass spectrometry and high performance liquid chromatography-inductively coupled plasma-mass spectrometry.

Pengfei Jin1, Xiaoli Liang2, Lufeng Xia2, Farid Jahouh3, Rong Wang3, Yongmei Kuang2, Xin Hu2.   

Abstract

Niuhuang Jiedu tablet (NHJDT) is a realgar-containing traditional Chinese medicine. A direct inductively coupled plasma-mass spectrometry (ICP-MS) method for the simultaneous determination of 20 trace elements (Mg, K, Ca, Na, Fe, As, Zn, Sr, Ba, Cu, Mn, Ni, Pb, V, Cr, Se, Co, Mo, Cd, Hg) in NHJDT, as well as in water, gastric fluid and intestinal fluid was established. Meanwhile, a high performance liquid chromatography-inductively coupled plasma-mass spectrometry (HPLC-ICP-MS) method was developed for the determination of arsenite (As(III)), arsenate (As(V)), monomethylarsonic acid (MMA), dimethylarsinic acid (DMA) and for the identification of arsenobetaine (AsB) and arsenocholine (AsC) in these extracts. Both methods were fully validated in the respect of linearity, sensitivity, precision, stability and accuracy. The reliability of the ICP-MS method was further evaluated using a certified standard reference material prepared from dried tomato leaves (NIST, SRM 1572a). The analysis showed that some manufacturers formulated lower amount of realgar than required in the Chinese Pharmacopoeia (ChP) in their preparations. In addition, almost same extraction profiles for total As and inorganic As were found in water and in gastrointestinal fluids, while higher extraction rates for other 19 elements were observed in gastrointestinal fluids. Our findings show that the toxicities of Hg, Cu, Cd and Pb in NHJDP are low, while the real As toxicity in NHJDT should be deeply investigated.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Arsenic; Arsenic species; High performance liquid chromatography; Inductively coupled plasma mass spectrometry; Niuhuang Jiedu tablet; Trace element

Mesh:

Substances:

Year:  2015        PMID: 26653746     DOI: 10.1016/j.jtemb.2015.09.006

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  5 in total

1.  Compatibility of Niuhuang Jiedu Tablets Results in Attenuated Arsenic Bioaccumulation and Consequent Protection against Realgar-Induced Toxicity in Mice.

Authors:  Wenfeng Xu; Shuo Xu; Yongmei Kuang; Xiaorong He; Pengfei Jin
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-23       Impact factor: 2.650

2.  Metabolic Profiling Analysis of the Alleviation Effect of the Fractions of Niuhuang Jiedu Tablet on Realgar Induced Toxicity in Rats.

Authors:  Wenfeng Xu; Yuehu Pei; Shuo Xu; Haifeng Wang; Pengfei Jin
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-23       Impact factor: 2.629

3.  Influences of Realgar-Indigo naturalis, A Traditional Chinese Medicine Formula, on the Main CYP450 Activities in Rats Using a Cocktail Method.

Authors:  Huan-Hua Xu; Fei-Ran Hao; Mei-Xi Wang; Si-Jia Ren; Ming Li; Hong-Ling Tan; Yu-Guang Wang; Xiang-Lin Tang; Cheng-Rong Xiao; Qian-De Liang; Yue Gao; Zeng-Chun Ma
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-21       Impact factor: 2.629

4.  The Absorption, Distribution, and Excretion of 18 Elements of Tibetan Medicine Qishiwei Zhenzhu Pills in Rats with Cerebral Ischemia.

Authors:  Yinglian Song; Ke Fu; Dewei Zhang; Min Xu; Ruixia Wu; Xueqing Xiong; Xianwu Liu; Lei Wu; Ya Guo; You Zhou; Xiaoli Li; Zhang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-28       Impact factor: 2.629

5.  Determination of 18 Trace Elements in 10 Batches of the Tibetan Medicine Qishiwei Zhenzhu Pills by Direct Inductively Coupled Plasma-Mass Spectrometry.

Authors:  Ke Fu; Yinglian Song; Dewei Zhang; Min Xu; Ruixia Wu; Xueqing Xiong; Xianwu Liu; Lei Wu; Ya Guo; You Zhou; Xiaoli Li; Zhang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-13       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.